Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies

被引：45

作者：

Luong, Me-Linh ^{[1
,2
]}

Filion, Charles ^{[1
]}

Labbe, Annie-Claude ^{[1
]}

Roy, Jean ^{[3
]}

Pepin, Jacques ^{[4
]}

Cadrin-Tourigny, Julia ^{[1
]}

Carignan, Stephane ^{[5
]}

Sheppard, Donald C. ^{[2
]}

Laverdiere, Michel ^{[1
]}

机构：

[1] Univ Montreal, Hop Maison Neuve Rosemont, Dept Microbiol, Montreal, PQ H1T 2M4, Canada

[2] McGill Univ, Ctr Hlth, Dept Microbiol, Montreal, PQ H3A 2B4, Canada

[3] Univ Montreal, Hop Maison Neuve Rosemont, Dept Med, Div Hematooncol, Montreal, PQ H1T 2M4, Canada

[4] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1H 5N4, Canada

[5] Univ Montreal, Hop Maison Neuve Rosemont, Dept Radiol, Montreal, PQ H1T 2M4, Canada

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2010年 / 68卷 / 02期

关键词：

Aspergillosis; Galactomannan; Bronchoalveolar lavage; Hematologic malignancies; INVASIVE PULMONARY ASPERGILLOSIS; CELL TRANSPLANT RECIPIENTS; ENZYME-IMMUNOASSAY; FUNGAL-INFECTIONS; ANTIGEN-DETECTION; MOLD INFECTIONS; DIAGNOSIS; FLUID; SERUM; ASSAY;

D O I：

10.1016/j.diagmicrobio.2010.03.017

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We conducted a single-center retrospective cohort study to determine the performance characteristics of the galactomannan (GM) assay in bronchoalveolar lavage (BAL) in patients with hematologic malignancies. Patients were classified as proven, probable, possible, or no invasive pulmonary aspergillosis (IPA), according to international guidelines. A total of 173 BAL samples from 145 patients were included. There were 5 proven, 7 probable, and 35 possible cases of IPA. Using a GM index cutoff of >= 0.5, the sensitivity, specificity, and positive and negative predictive values (PPV and NPV, respectively) of the BAL GM assay were 100%, 78%, 26%, and 100%, respectively. Using a GM index cutoff of >= 2.0, sensitivity and NPV remained 100%, but specificity and PPV increased to 93% and 50%, respectively. The BAL GM assay is a highly sensitive screening test for IPA in patients with hematologic malignancies. Increasing the cutoff value to 2.0 would improve the performance of this assay. (C) 2010 Elsevier Inc. All rights reserved.

引用

页码：132 / 139

页数：8

共 50 条

[21] Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
Svensson, Tobias
Lundstrom, Kristina Lamberg
Hoglund, Martin
Cherif, Honar
UPSALA JOURNAL OF MEDICAL SCIENCES, 2017, 122 (01) : 56 - 60
[22] Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance
Racil, Zdenek
Kocmanova, Iva
Toskova, Martina
Buresova, Lucie
Weinbergerova, Barbora
Lengerova, Martina
Rolencova, Monika
Winterova, Jana
Hrncirova, Kristyna
Volfova, Pavlina
Skrickova, Jana
Mayer, Jiri
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (12) : E874 - E881
[23] The Utility of Galactomannan and Polymerase Chain Reaction Assays in Bronchoalveolar Lavage for Diagnosis of Chronic Pulmonary Aspergillosis
Chowdhury, Mohit
Singh, Gagandeep
Pandey, Mragnayani
Mishra, Himanshu
Meena, Ved Prakash
Sethi, Prayas
Singh, Amandeep
Prakash, Bindu
Upadhyay, Ashish Datt
Mohan, Anant
Sinha, Sanjeev
Xess, Immaculata
Wig, Naveet
Kabra, Sushil Kumar
Ray, Animesh
MYCOPATHOLOGIA, 2023, 188 (06) : 1041 - 1053
[24] The utility of bronchoalveolar lavage fluid and serum galactomannan assay in patients with nonresolving pneumonia in a tertiary care hospital
Savio, Jayanthi
Devaraj, Uma
Krishnaswamy, Uma Maheshwari
D'Souza, George
Ramachandran, Priya
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (01): : 135 - 141
[25] Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis
Lim, So Yun
Lee, Yun Woo
Jung, Jiwon
Kim, Min Jae
Chong, Yong Pil
Lee, Sang-Oh
Choi, Sang-Ho
Kim, Yang Soo
Choi, Eun-Ji
Park, Han-Seung
Lee, Jung-Hee
Lee, Je-Hwan
Lee, Kyoo-Hyung
Kim, Sung-Han
MYCOSES, 2021, 64 (09) : 1124 - 1131
[26] THE PROGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN SARCOIDOSIS
TUKIAINEN, P
TASKINEN, E
RISKA, H
SARCOIDOSIS, 1994, 11 (01): : 69 - 72
[27] Evaluation of the diagnostic accuracy of galactomannan from the bronchoalveolar lavage fluid of patients with suspected invasive pulmonary aspergillosis
Bernardi, Rafaela Manzoni
Holler, Sizuane Rieger
Correa de Almeida, Ellis Gabriela
Anton, Camila
Machado, Felipe Dominguez
Silva, Denise Rossato
REVISTA IBEROAMERICANA DE MICOLOGIA, 2022, 39 (02): : 31 - 35
[28] Prognostic Value of Bronchoalveolar Lavage in Patients with Non-HIV Pneumocystis Pneumonia
Tamai, Koji
Tachikawa, Ryo
Tomii, Keisuke
Nagata, Kazuma
Otsuka, Kojiro
Nakagawa, Atsushi
Otsuka, Kyoko
Matsumoto, Takeshi
Monden, Kazuya
Takeshita, Jumpei
Tanaka, Kosuke
Kawamura, Takahisa
Otoshi, Takehiro
Fujimoto, Daichi
INTERNAL MEDICINE, 2014, 53 (11) : 1113 - 1117
[29] Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation
Ardi, Pegah
Daie-Ghazvini, Roshanak
Hashemi, Seyed Jamal
Salehi, Mohammad Reza
Bakhshi, Heidar
Rafat, Zahra
Zareei, Mahdi
Getso, Muhammad
Basiri, Solmaz
Sarwestani, Hasti Kamali
Boroujeini, Zeinab Borjian
Ahmadikia, Kazem
MICROBIAL PATHOGENESIS, 2020, 147
[30] Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies
Ogimi, Chikara
Waghmare, Alpana A.
Kuypers, Jane M.
Xie, Hu
Yeung, Cecilia C.
Leisenring, Wendy M.
Seo, Sachiko
Choi, Su-Mi
Jerome, Keith R.
Englund, Janet A.
Boeckh, Michael
CLINICAL INFECTIOUS DISEASES, 2017, 64 (11) : 1532 - 1539

← 1 2 3 4 5 →